HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Hiberix

Hib conjugated to tetanus toxoid

Networked: 7 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Synthetic Vaccines: 1073
      - Conjugate Vaccines: 3555
        Hiberix: 7
    - Bacterial Vaccines: 529
      - Haemophilus Vaccines: 37
        Hiberix: 7
Biological Factors: 2472
- Antigens: 143924
  - Synthetic Vaccines: 1073
    - Conjugate Vaccines: 3555
      - Hiberix: 7

Experts

1.	Kostinov, M P: 1 article (07/2011)
2.	Lavrenteva, N E: 1 article (07/2011)
3.	Protasov, A D: 1 article (07/2011)
4.	Ryzhkov, A A: 1 article (07/2011)
5.	Zhestkov, A V: 1 article (07/2011)
6.	Diallo, Dapa: 1 article (01/2011)
7.	Dicko, Alassane: 1 article (01/2011)
8.	Doumbo, Ogobara K: 1 article (01/2011)
9.	Ellis, Ruth D: 1 article (01/2011)
10.	Fay, Michael P: 1 article (01/2011)

Related Diseases

1.	Whooping Cough (Pertussis) 07/01/2007 - "These were GlaxoSmithKline Biologicals' (GSK) Haemophilus influenzae type b vaccine (Hib-TT, Hiberix) administered with the local Government Pharmaceutical Organization's (GPO) diphtheria-tetanus-pertussis whole cell (DTPw) vaccine, Hib-TT mixed with GPO's DTPw vaccine, or Hib-IT mixed with GSKs' DTPw vaccine (Tritanrix). " 03/01/2006 - "GlaxoSmithKline Biologicals has developed a new pentavalent combined diphtheria-tetanus-whole cell pertussis-hepatitis B/Hib (DTPw-HB/Hib) vaccine containing 5 microg of polyribosylribitol phosphate (PRP), and we assessed the immunogenicity and reactogenicity of primary and booster vaccination of healthy children with this new vaccine compared with a reference regimen consisting of the licensed DTPw-HB (Tritanrix) and Hib (Hiberix) vaccines given as simultaneous concomitant injections. " 01/01/2003 - "This study was aimed to determine the levels of antibodies against Bordetella pertussis, Haemophilus influenzae type b (Hib) and Poliovirus type 1 in preterm children after immunization with acellular pertussis (Infanrix-DTPa) and Hib conjugate (Hiberix) vaccines as well as inactivated vaccine against poliomyelitis (Imovax Polio). " 05/01/1999 - "The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. "
2.	Poliomyelitis (Polio) 01/01/2003 - "32 children were given 3 doses of Infanrix-DTPa and Hiberix vaccines as well as Imovax Polio vaccine. " 01/01/2003 - "Samples of blood were taken from children 4 weeks after application the 3-rd dose of vaccines and compared with the initial levels of antibodies (seroconversion was evaluated in 32 children immunized with both infanrix-DTPa and Hiberix and in 20 ones immunized with Imovax Polio). " 01/01/2003 - "This study was aimed to determine the levels of antibodies against Bordetella pertussis, Haemophilus influenzae type b (Hib) and Poliovirus type 1 in preterm children after immunization with acellular pertussis (Infanrix-DTPa) and Hib conjugate (Hiberix) vaccines as well as inactivated vaccine against poliomyelitis (Imovax Polio). "
3.	Malaria 01/19/2011 - "In the Phase 2 portion of the study (n = 300), no impact on parasite density or clinical malaria was seen; however, children who received the study vaccine had a higher frequency of anaemia (defined as haemoglobin < 8.5 g/dL) compared to those who received the comparator vaccine (Hiberix). "
4.	Tetanus 07/01/2007 - "These were GlaxoSmithKline Biologicals' (GSK) Haemophilus influenzae type b vaccine (Hib-TT, Hiberix) administered with the local Government Pharmaceutical Organization's (GPO) diphtheria-tetanus-pertussis whole cell (DTPw) vaccine, Hib-TT mixed with GPO's DTPw vaccine, or Hib-IT mixed with GSKs' DTPw vaccine (Tritanrix). " 03/01/2006 - "GlaxoSmithKline Biologicals has developed a new pentavalent combined diphtheria-tetanus-whole cell pertussis-hepatitis B/Hib (DTPw-HB/Hib) vaccine containing 5 microg of polyribosylribitol phosphate (PRP), and we assessed the immunogenicity and reactogenicity of primary and booster vaccination of healthy children with this new vaccine compared with a reference regimen consisting of the licensed DTPw-HB (Tritanrix) and Hib (Hiberix) vaccines given as simultaneous concomitant injections. " 05/01/1999 - "The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. "
5.	Hepatitis B 09/15/2001 - "To those aged 2 and 6 months (group 1: 108 children) it was administered the association DTPw + Hepatitis B + Hib (Tritanrix-HB + Hiberix) with a volume of injection of 0,5 ml, and to those aged 4 months (group 2: 120 children) the association DTPw + Hib (Anatoxal Diteper + Hibtiter) with a volume of 1 ml. The injection was applied in the thigh and paracetamol was indicated in the following 24 hours. " 03/01/2006 - "GlaxoSmithKline Biologicals has developed a new pentavalent combined diphtheria-tetanus-whole cell pertussis-hepatitis B/Hib (DTPw-HB/Hib) vaccine containing 5 microg of polyribosylribitol phosphate (PRP), and we assessed the immunogenicity and reactogenicity of primary and booster vaccination of healthy children with this new vaccine compared with a reference regimen consisting of the licensed DTPw-HB (Tritanrix) and Hib (Hiberix) vaccines given as simultaneous concomitant injections. " 05/01/1999 - "The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. "

Related Drugs and Biologics

1.	Vaccines
2.	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)
3.	Inactivated Vaccines
4.	Pentetic Acid (DTPA)
5.	Antibodies
6.	Haemophilus influenzae HibTITER protein
7.	Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)
8.	Conjugate Vaccines
9.	Inactivated Poliovirus Vaccine (Salk Vaccine)
10.	Phosphates (Orthophosphate)

Related Therapies and Procedures

1.	Injections